To exclude the possibility that high cholesterol levels after APOO deficiency is secondary to obesity-related excess cholesterol synthesis, we examined the HMG-CoA reductase (HMGCR) expression and cholesterol biosynthesis rate in the liver using 3H-labeled H2O incorporation assays. The gene discussed is HMGCR; the disease is Obesity.